These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6345112)

  • 61. New salicylate therapies for ulcerative colitis.
    Bruckstein AH
    Postgrad Med; 1990 Sep; 88(3):79-82, 84, 89. PubMed ID: 1975952
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmaceutic development: mesalazine.
    Osterwald HP
    Scand J Gastroenterol Suppl; 1990; 172():43-6. PubMed ID: 2353170
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas.
    Chatzinoff M; Guarino JM; Corson SL; Batzer FR; Friedman LS
    Dig Dis Sci; 1988 Jan; 33(1):108-10. PubMed ID: 2892654
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Unilateral balsalazide-induced eosinophilic pneumonia in an ulcerative colitis patient.
    McGrane J; Paravasthu M; Candlish W; Gravil J
    J R Coll Physicians Edinb; 2010 Sep; 40(3):216-8. PubMed ID: 21127763
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Balsalazide in treating colonic diseases.
    Tursi A
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1555-63. PubMed ID: 19708827
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid.
    Dew MJ; Hughes P; Harries AD; Williams G; Evans BK; Rhodes J
    Br Med J (Clin Res Ed); 1982 Oct; 285(6347):1012. PubMed ID: 6127137
    [No Abstract]   [Full Text] [Related]  

  • 67. Pharmacokinetics of sulfasalazine metabolites in rats following concomitant oral administration of riboflavin.
    Chungi VS; Dittert LW; Shargel L
    Pharm Res; 1989 Dec; 6(12):1067-72. PubMed ID: 2576130
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sulfasalazine and new analogues.
    Friedman G
    Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653
    [No Abstract]   [Full Text] [Related]  

  • 69. 5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis.
    Walker AM; Szneke P; Bianchi LA; Field LG; Sutherland LR; Dreyer NA
    Am J Gastroenterol; 1997 May; 92(5):816-20. PubMed ID: 9149192
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds.
    Rijk MC; van Schaik A; van Tongeren JH
    Scand J Gastroenterol; 1988 Jan; 23(1):107-12. PubMed ID: 2894070
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.
    Naganuma M; Iwao Y; Ogata H; Inoue N; Funakoshi S; Yamamoto S; Nakamura Y; Ishii H; Hibi T
    Inflamm Bowel Dis; 2001 Aug; 7(3):221-5. PubMed ID: 11515848
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Balsalazide disodium for the treatment of ulcerative colitis.
    Patil SA; Moss AC
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):177-84. PubMed ID: 19072352
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Renal function was not impaired by treatment with 5-aminosalicylic acid in rats and man.
    Diener U; Tuczek HV; Fischer C; Maier K; Klotz U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(3):278-82. PubMed ID: 6147767
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients.
    Jahraus CD; Bettenhausen D; Malik U; Sellitti M; St Clair WH
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1483-7. PubMed ID: 16099600
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I; Kawasaki M; Matsuda A; Kataoka M; Kokurba Y
    Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development.
    Peppercorn MA
    Ann Intern Med; 1984 Sep; 101(3):377-86. PubMed ID: 6147110
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Inhibition of intestinal leukotriene formation as a possible mechanism of action of sulfasalazine, 5-aminosalicylic acid and 4-aminosalicylic acid].
    Peskar BM
    Klin Wochenschr; 1988 Nov; 66(22):1147-50. PubMed ID: 2907066
    [No Abstract]   [Full Text] [Related]  

  • 78. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
    Kam L; Cohen H; Dooley C; Rubin P; Orchard J
    Am J Gastroenterol; 1996 Jul; 91(7):1338-42. PubMed ID: 8677990
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Therapeutic effectiveness and tolerance of 5-aminosalicylic acid in short term treatment of patients with ulcerative colitis at a low or medium phase of activity.
    Bresci G; Carrai M; Venturini G; Gambardella L
    Int J Tissue React; 1990; 12(4):243-6. PubMed ID: 1980911
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Efficacy and tolerability of 5-aminosalicylic acid in the short-term treatment of ulcerative rectocolitis during the mild or moderate stage].
    Bresci G; Carrai M; Venturini G; Gambardella L
    Minerva Dietol Gastroenterol; 1990; 36(1):31-3. PubMed ID: 1970855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.